Puttagunta Sailaja has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 8333 shares of Iterum Therapeutics plc ($ITRM) on December 01, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 1, 2023 | Iterum Therapeutics plc | $ITRM | Puttagunta Sailaja | Chief Medical Officer | A | Ordinary Shares | 8333 | $0.00 | 13,302.0000 | 12,236,607 | 167.70% | 0.07% |
| Dec. 1, 2023 | Iterum Therapeutics plc | $ITRM | Puttagunta Sailaja | Chief Medical Officer | F | Ordinary Shares | 2933 | $2.12 | 10,369.0000 | 12,236,607 | 22.05% | 0.02% |
| Dec. 1, 2023 | Iterum Therapeutics plc | $ITRM | Puttagunta Sailaja | Chief Medical Officer | M | Restricted Share Units | 8333 | $0.00 | 16,666.0000 | 12,236,607 | 33.33% | 0.07% |
| March 31, 2023 | Iterum Therapeutics plc | $ITRM | Puttagunta Sailaja | Chief Medical Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 12,236,607 | 9999.99% | 0.61% |